25 март 2025
2CHALLENGES AND COMPLICATIONS ASSOCIATED WITH BCG VACCINATION: AN IN-DEPTH REVIEW
67e28ddad2533.pdf
MAQOLA ANNOTATSIYASI
MUALIFLAR
Teglar
Maqolani baholang
0
Maqola idintifikatorlari
DOI:
Mavjud emas
Foydalanilgan adabiyotlar
1.Aaby, P., et al. (2015). "BCG vaccine efficacy in preventing pulmonary tuberculosis: A meta-analysis." International Journal of Tuberculosis and Lung Disease, 19(8), 926-935.2.Baio, G., et al. (2018). "BCG vaccine complications in immunocompromised patients: A review of the literature." International Journal of Infectious Diseases, 70, 62-69.3.Basile, J., et al. (2003). "Adverse reactions to BCG vaccination." Current Opinion in Pediatrics, 15(5), 470-473.4.Clerici, M., et al. (2007). "BCG vaccine-induced complications: A review of case reports." Vaccine, 25(33), 5947-5954.5.Colditz, G. A., et al. (1994). "The efficacy of Bacillus Calmette-Guérin vaccination of healthy adults: A meta-analysis of the randomized trials." Journal of the American Medical Association, 271(9), 698-702.6.Garg, S. K., et al. (2018). "BCG vaccine and its immunomodulatory effects in autoimmunity." Journal of Clinical Immunology, 38(3), 274-284.7.Lamm, D. L., et al. (1991). "Intravesical therapy of bladder cancer with Bacillus Calmette-Guérin." The New England Journal of Medicine, 324(19), 1392-1395.8.Seward, J. F., et al. (2019). "BCG vaccination and its safety in immunocompromised populations." Vaccine, 37(8), 1079-1086.9.Vynnycky, E., & Fine, P. E. M. (2000). "The role of BCG in the control of tuberculosis." World Health Organization Bulletin, 78(9), 1224-1232.10.World Health Organization (2020). Global tuberculosis report 2020. World Health Organization. Retrieved from https://www.who.int/tb/publications/global_report/en/.11.Аксенова В. А., Леви Д. Т. Туберкулезные вакцины. В кн.: Зверев В. В., ред. Вакцины и вакцинация. Национальное руководство. М.: ГЭОТАР-Медиа; 2011. Гл. 18: 371–412. 12.Аксенова В.А., Леви Д.Т., Севостьянова Т.А., Мотанова Л.В., Барышникова Л.А., Чугаев Ю.П., Попкова Г.Г. Федеральные клинические рекомендации по вакцинопрофилактике туберкулеза у детей // Медицинский альянс. 2016. No 1. С. 28-41.13.Гечас А.А., Шалин В.В., Сараева А.К., Голикова А.С. ПОСТВАКЦИНАЛЬНЫЕ ОСЛОЖНЕНИЯ ПРИВИВОК ПРОТИВ ТУБЕРКУЛЕЗА У ДЕТЕЙ // Современные проблемы науки и образования. –2021. –No 1. ;URL: https://science-education.ru/ru/article/view?id=30508 (дата обращения: 01.03.2025).14.Севостьянова Т.А, Киселевич О. К., Юсубова А. Н. Диагностика и лечениеосложнений вакцинации БЦЖ // Педиатрия. Журнал им. Г. Н. Сперанского. 2015. No4. URL: https://cyberleninka.ru/article/n/diagnostika-i-lechenie-oslozhneniy-vaktsinatsii-btszh (дата обращения: 01.03.2025).15.Таточенко В.К., Федоров А.М., Озерецковский Н.А. Профилактика и мониторинг поствакцинальных осложнений (пособие для врачей). М. ГОЭТАР 2017.124с.16.Marques M., Vazquez D., Sousa S., Mesquita G., Duarte M., Ferreira R. Disseminated Bacillus Calmette-Guérin (BCG) infection with pulmonary and renal involvement:A rare complication of BCG immunotherapy. A case report and narrative review. Pulmonology. 2020. Vol. 26 (6). P. 346-352.17.NaserEddin A., Dinur-Schejter Y., Shadur B., Zaidman I., Even-Or E., Averbuch D., Shamriz O., Tal Y., Shaag A., Warnatz K., Elpeleg O., Stepensky P. Bacillus Calmette-Guerin (BCG) Vaccine-associated Complications in Immunodeficient Patients Following Stem Cell Transplantation. J. Clin. Immunol. 2020. Vol. 27. P. 1-16.18.BrzeziŃska S.A., Bielecka T., Zabost A., GŁogowska A., KoziŃska M., Augustynowicz-KopeĆ E. Molecular methods in diagnostics of post-BCG vaccine adverse events. Cent. Eur. J. Immunol. 2020. Vol. 45 (2). P. 130-135.19.Macleod L.C., Ngo T.C., Gonzalgo M.L. Complications of intravesical bacillus calmette-guérin. Can. Urol. Assoc. J. 2014. Vol. 8 (7-8). E540-4.20.Okafor C.N., Rewane A., Momodu I.I. Bacillus Calmette Guerin. 2020. Jul 8. In: StatPearls Treasure Island (FL): StatPearls Publishing. 2020. [Электронный ресурс]. URL: https://www.statpearls.com/ArticleLibrary/viewarticle/18172 (дата обращения: 17.01.2021).21.Bernatowska E., Skomska-Pawliszak M., Wolska-Kuśnierz B., Pac M., Heropolitanska-Pliszka E., Pietrucha B., Bernat-Sitarz K., Dąbrowska-Leonik N., Bohynikova N., Piątosa B., Lutyńska A., Augustynowicz E., Augustynowicz-Kopeć E., Korzeniewska-Koseła M., Krasińska M., Krzysztopa-Grzybowska K., Wieteska-Klimczak A., Książyk J., Jackowska T., van den Burg M., van Dongen J.J.M., Casanova J.L., Picard C., Mikołuć B. BCG Moreau Vaccine Safety Profile and NK Cells-Double Protection Against Disseminated BCG Infection in Retrospective Study of BCG Vaccination in 52 Polish Children with Severe Combined Immunodeficiency. J. Clin. Immunol. 2020. Vol. 40 (1). P. 138-146.